Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirena vs Oral Medroxyprogesterone Acetate in Nonatypical Endometrial Hyperplasia
NCT06904274Phase 3Withdrawn
- Sponsor
- Bayer
- Start
- Nov 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of levonorgestrel intrauterine system in endometrial hyperplasia (EH), sponsored by Bayer. Planned start Nov 2025; status: withdrawn.
02
Drugs
levonorgestrel intrauterine system
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on NCT06904274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06904274.